Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients

September 6, 2019 updated by: katerina kotzampassi, Aristotle University Of Thessaloniki

Comparative Assessment of Phase Angle, Lean Body Mass Index and Tissue Edema to Assess the Nutritional Status and Immediate Outcome of Cardiac Surgery Patients:an Open, Prospective Study of Observation / Recording

In general, malnutrition in surgical patients is associated with a higher risk of postoperative infections, decreased immune response, more cardiac complications, prolonged mechanical ventilation , and a higher rate of reimportation due to several other complications than lead to an increase in morbidity and mortality, a prolongation of the total hospitalization time in the ICU[intensive care unit ] and the chamber, and a delay in the healing of the surgical trauma .

The presence of a low percentage of lean mass, as calculated by the technique of bioelectric conductivity, practically means a small percentage of muscle tissue. However, muscle tissue is an important, if not the only source of amino acids for both protein synthesis and gluconeogenesis in stress conditions, such as surgery and the first postoperative days. Thus, post-operative patients in general, and cardio-operated patients, in particular, having a low lean mass have minimal reserves to the stress requirements, resulting in an increased risk of complications.

In the last few years, the most reliable indicator of malnutrition- in addition to the lean mass index - began to be considered the phase angle, which is also calculated when measuring the bioreduction of electrical conductivity, although there is a very recent challenge . The phase angle expresses the relationship between the electrical reactance, i.e. the state of the cell membrane, to resist the permeability and the resistance, i.e. the restriction to the flow of the electrical current through the body, mainly related to the water of the tissues . Like the FFM[fat-free mass]- index, the phase angle uses the total water of the tissues, and thus also reflects the cell mass. In addition, however, it also measures the resistance of cell membranes, so it also evaluates their quality and is therefore considered to be a reliable indicator of poor nutritional status , although some also maintain demur due to the possible poor distribution of extracellular fluid in cardiological patients.

From all of the above, it appears that there are some gaps in the evaluation of the patients who are going to undergo cardiac surgery regarding their nutritional status, both because the classic nutrition control indicators are not fully documented as being reliable for these patients, and there are no studies to monitor and compare body composition directly to any other index postoperatively.

Study Overview

Status

Completed

Conditions

Detailed Description

The study protocol-mandated baseline data will include demographics, comorbidities, EuroSCORE[European System for Cardiac Operative Risk Evaluation] II, C-reactive protein, left ventricular ejection fraction (by transthoracic echocardiography) and peak expiratory flow rate (assessed by spirometry). Physical performance status will be assessed by APACHE [Acute Physiology And Chronic Health Evaluation] II score. Furthermore, SOFA [Sequential [Sepsis-related] Organ Failure Assessment] score will be assessed preoperatively and up to 7th postoperative day.

Preoperatively and on the 7th postoperative day, the following parameters will be calculated or measured and then recorded:

  • Anthropometric data including body height, weight and waist circumference measurement, estimation of waist/circumference ratio and calculation of body mass index [BMI].
  • Nutritional status will be assessed by MUST[Malnutrition Universal Screening Tool] score
  • Body composition analysis using bioelectrical impedance analysis [BIA], will be performed for the calculation of FFM [fat-free mass] and fat mass [FM] indicators, intracellular, extracellular and total water [ICW, ECW, TBW] and phase angle parameter [PhA]. Additionally, muscular power will be assessed by handgrip strength [HGS], the upper third triangle perimeter and skin fold thickness will be measured.
  • Daily calorie and protein needs of each patient will be calculated

During hospitalization, the following parameters will be recorded:

  • Type of diet [parenteral, intestinal, oral]
  • Post-operative infections involving respiratory system, medieval space, sternum trauma, lower limb trauma (if present) and endocarditis.
  • The occurrence of organ dysfunction or sepsis. Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. For clinical operationalization, organ dysfunction will be represented by an increase in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score of 2 points or more, which will be associated with an in-hospital mortality greater than 10%.
  • Thromboembolic events such as stroke, peripheral venous thrombosis and pulmonary embolism.
  • Acute renal failure.
  • Re-operation for bleeding.
  • Need for inotropic or vasoactive support.
  • Hospitalization data (intubation> 24 hours, duration of mechanical ventilation and ICU stay, duration of hospital stay, in-hospital mortality

Study Type

Observational

Enrollment (Actual)

179

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Greece
      • Thessaloníki, Greece, 56346
        • Ahepa University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled to undergo cardiac surgery for coronary revascularization or valvular heart disease

Description

Inclusion Criteria:

  • age >18 years
  • planned introduction for cardiac operation with CPB[cardiopulmonary bypass]
  • coronary artery bypass surgery
  • heart valve surgery [heart valve surgery]

Exclusion Criteria:

  • non-consent of the patient
  • urgent admissions - operations
  • pacemaker exist
  • congenital heart disease
  • recent [<3-month] open-heart surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase angle in patients undergoing cardiac surgery as indicator of their nutrition status.
Time Frame: 7 days post operation
Phase angle [PhA(°) = (reactance/electrical resistance) × (180°/Π)] will be measured in degrees using bioelectrical impedance analysis and check whether it can be considered as a reliable indicator of the nutrition status of cardiac surgery patients undergoing cardiac surgery during the preoperative and postoperative periods. PhA will be calculated by using the sum of impedance and reactance of the right arm, trunk, and right leg and based on the following equation, PhA(°) = (Reactance/Resistance) × (180°/Π). Π is the mathematical value of 3.1415 and This conversion is performed to convert the final value from radians into degrees.The normal range of phase angle is 5.84 ± 0.75.The primary change is the reduction of the mean phase angle postoperative by 1.0 unit (standard deviation ± 2.0) and this leads to increased morbidity, mortality.
7 days post operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FFM[fat-free mass] index(kilograms/(meter x meter)- kg/m-2) in patients undergoing cardiac surgery as indicator of their nutrition status
Time Frame: 7 days post operation
measure of FFM [fat-free mass] index( kgm-2) using bioelectrical impedance analysis and check if it can be a reliable indicator of the nutrition status of patients undergoing cardiac surgery during the preoperative and post-operative periods and how this leads to increased morbidity, mortality.
7 days post operation
Tissue edema index [extracellular(Litre) / total water(Litre) - ECW / TBW] in patients undergoing cardiac surgery as indicator of their nutrition status.
Time Frame: 7 days post operation
measure of the tissue edema index [extracellular(Litre) / total water(Litre) - ECW / TBW] using bioelectrical impedance analysis and check if it can be a reliable indicator of the nutrition status of patients undergoing cardiac surgery during the preoperative and post-operative periods and if this associated with postoperative complications.
7 days post operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aristotle University Of Thessaloniki

Investigators

  • Study Director: Katerina Kotzampassi, Aristotle University Of Thessaloniki

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 6, 2018

Primary Completion (ACTUAL)

August 15, 2019

Study Completion (ACTUAL)

September 1, 2019

Study Registration Dates

First Submitted

August 11, 2018

First Submitted That Met QC Criteria

August 21, 2018

First Posted (ACTUAL)

August 23, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 9, 2019

Last Update Submitted That Met QC Criteria

September 6, 2019

Last Verified

September 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CardioMass

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe